Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia

Table 5

Areas under the ROC curves of the target PSA glycopeptides.

Glycan composition	AUC	value	Cancer threshold	Sensitivity	Specificity
H5N4S1F1	0.7381 ± 0.0661	0.009	<0.470	92.9%	59.0%
Monosialylated	0.7102 ± 0.0681	0.015	<1.060	100%	47.5%
Sialylated	0.6938 ± 0.0763	0.025	<1.260	68.8%	75%
Unfucosylated	0.6758 ± 0.0699	0.041	<1.065	87.5%	60%
Total	0.7242 ± 0.0662	0.009	<1.815	87.5%	60%

AUC was calculated based on the samples which could be detected for the indicated glycoform or grouped glycoforms.